▶ 調査レポート

てんかん発作治療の世界市場2020-2030:治療別(ミダゾラム、アルプラゾラム、ジアゼパム、ロラゼパム、フェニトイン、その他)、種類別、投与経路別、流通チャンネル別

• 英文タイトル:Epileptic Seizures Treatment Market (Therapeutic: Midazolam, Alprazolam, Diazepam, Lorazepam, Phenytoin, Fosphenytoin, and Others; Type: Repetitive Seizures, Status Epilepticus, and Others; Route of Administration: Oral/Buccal, Rectal, Nasal, and Parenteral; and Distribution Channel: Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020-2030

Transparency Market Researchが調査・発行した産業分析レポートです。てんかん発作治療の世界市場2020-2030:治療別(ミダゾラム、アルプラゾラム、ジアゼパム、ロラゼパム、フェニトイン、その他)、種類別、投与経路別、流通チャンネル別 / Epileptic Seizures Treatment Market (Therapeutic: Midazolam, Alprazolam, Diazepam, Lorazepam, Phenytoin, Fosphenytoin, and Others; Type: Repetitive Seizures, Status Epilepticus, and Others; Route of Administration: Oral/Buccal, Rectal, Nasal, and Parenteral; and Distribution Channel: Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020-2030 / MRC20A40資料のイメージです。• レポートコード:MRC20A40
• 出版社/出版日:Transparency Market Research / 2020年10月30日
• レポート形態:英文、PDF、219ページ
• 納品方法:Eメール
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥602,680 (USD5,795)▷ お問い合わせ
  Multi User¥914,680 (USD8,795)▷ お問い合わせ
  Corporate License¥1,226,680 (USD11,795)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートは、てんかん発作治療の世界市場について調査し、序論、仮定/調査手法、エグゼクティブサマリー、市場概要、キーインサイト、治療別(ミダゾラム、アルプラゾラム、ジアゼパム、ロラゼパム、フェニトイン、その他)分析、種類別分析、投与経路別分析、流通チャンネル別分析、地域別(北米、ヨーロッパ、アジア太平洋、中南米、中東/アフリカ)分析、競争状況などを掲載しています。
・序論
・仮定/調査手法
・エグゼクティブサマリー
・市場概要
・キーインサイト
・てんかん発作治療の世界市場規模:治療別(ミダゾラム、アルプラゾラム、ジアゼパム、ロラゼパム、フェニトイン、その他)
・てんかん発作治療の世界市場規模:種類別
・てんかん発作治療の世界市場規模:投与経路別
・てんかん発作治療の世界市場規模:流通チャンネル別
・てんかん発作治療の世界市場規模:地域別(北米、ヨーロッパ、アジア太平洋、中南米、中東/アフリカ)
・競争状況

Epileptic Seizures Treatment Market – Scope of the Report

TMR’s report on the global epileptic seizures treatment market studies the past as well as current growth trends and opportunities to gain valuable insights of these indicators for the market during the forecast period from 2020 to 2030. The report provides the overall market revenue of the global epileptic seizures treatment market for the period 2018–2030, considering 2019 as the base year and 2030 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global epileptic seizures treatment market for the forecast period.

The report has been prepared after extensive primary and secondary research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global epileptic seizures treatment market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts have employed a combination of top-down and bottom-up approaches to study various phenomena in the global epileptic seizures treatment market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments and sub-segments included in the scope of the study. Furthermore, the report sheds light on changing competitive dynamics in the global epileptic seizures treatment market. These indices serve as valuable tools for existing market players as well as for entities interested in participating in the global epileptic seizures treatment market.

The report delves into the competition landscape of the global epileptic seizures treatment market. Key players operating in the global epileptic seizures treatment market have been identified, and each one of them has been profiled for their distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players in the global epileptic seizures treatment market that have been profiled in this report.

Key Questions Answered in Epileptic Seizures Treatment Market Report

What is the sales/revenue generated by each therapeutic, type, route of administration, and distribution channel segment of the global epileptic seizures treatment market across all regions during the forecast period?
What are the opportunities in the global epileptic seizures treatment market?
What are the major drivers, restraints, opportunities, and threats in the market?
Which region is likely to expand at the fastest CAGR during the forecast period?
Which epileptic seizures treatment segments are expected to generate the highest revenue globally in 2030? Which segment is projected to expand at the highest CAGR during the forecast period?
What is the market share or position of different companies operating in the global market in 2019?
Epileptic Seizures Treatment Market – Research Objectives and Research Approach

The comprehensive report on the global epileptic seizures treatment market begins with an overview of the market, followed by the scope and objectives of this study. Following this, the report provides detailed explanation of the objectives behind this study, pipeline analysis, disease prevalence in key countries, key industry events, and impact of COVID-19 in global epileptic seizures treatment market have been provided.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into small ones. The entire report comprises an exhaustive collection of graphs and tables appropriately interspersed in the entire compilation. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global epileptic seizures treatment market in terms of therapeutic, type, route of administration, distribution channel, and region. Key segments under each criteria have been studied at length, and the market share for each of these at the end of 2030 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global epileptic seizures treatment market.

レポート目次

1. Preface

1.1. Market Definition and Scope

1.2. Market Segmentation

1.3. Key Research Objectives

1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Epileptic Seizures Treatment Market

4. Market Overview

4.1. Introduction

4.1.1. Market Definition

4.1.2. Industry Evolution / Developments

4.2. Overview

4.3. Market Dynamics

4.3.1. Drivers

4.3.2. Restraints

4.3.3. Opportunities

4.4. Global Epileptic Seizures Treatment Market Analysis and Forecast, 2018–2030

4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

5.1. Pipeline Analysis

5.2. Disease Prevalence & Incidence Rate globally with key countries

5.3. Key Industry Events (mergers, acquisitions, collaborations, partnerships, etc.)

5.4. COVID-19 Pandemic Impact on Industry (Value Chain and Short / Mid / Long Term Impact)

6. Global Epileptic Seizures Treatment Market Analysis and Forecast, by Therapeutics

6.1. Introduction & Definition

6.2. Key Findings / Developments

6.3. Market Value Forecast, by Therapeutics, 2018–2030

6.3.1. Midazolam

6.3.2. Alprazolam

6.3.3. Diazepam

6.3.4. Lorazepam

6.3.5. Phenytoin

6.3.6. Fosphenytoin

6.3.7. Others

6.4. Market Attractiveness Analysis, by Therapeutics

7. Global Epileptic Seizures Treatment Market Analysis and Forecast, by Type

7.1. Introduction & Definition

7.2. Key Findings / Developments

7.3. Market Value Forecast, by Type, 2018–2030

7.3.1. Repetitive Seizures

7.3.2. Status Epilepticus

7.3.2.1. Convulsive Status Epilepticus

7.3.2.2. Non-convulsive Status Epilepticus

7.3.3. Others

7.4. Market Attractiveness Analysis, by Type

8. Global Epileptic Seizures Treatment Market Analysis and Forecast, by Route of Administration

8.1. Introduction & Definition

8.2. Key Findings / Developments

8.3. Market Value Forecast, by Route of Administration, 2018–2030

8.3.1. Oral/Buccal

8.3.2. Rectal

8.3.3. Nasal

8.3.4. Parenteral

8.4. Market Attractiveness Analysis, by Route of Administration

9. Global Epileptic Seizures Treatment Market Analysis and Forecast, by Distribution Channel

9.1. Introduction & Definition

9.2. Key Findings / Developments

9.3. Market Value Forecast, by Distribution Channel, 2018–2030

9.3.1. Hospital Pharmacies

9.3.2. Retail Pharmacies

9.3.3. Online Pharmacies

9.4. Market Attractiveness Analysis, by Distribution Channel

10. Global Epileptic Seizures Treatment Market Analysis and Forecast, by Region

10.1. Key Findings

10.2. Market Value Forecast, by Region

10.2.1. North America

10.2.2. Europe

10.2.3. Asia Pacific

10.2.4. Latin America

10.2.5. Middle East & Africa

10.3. Market Attractiveness Analysis, by Country/Region

11. North America Epileptic Seizures Treatment Market Analysis and Forecast

11.1. Introduction

11.1.1. Key Findings

11.2. Market Value Forecast, by Therapeutics, 2018–2030

11.2.1. Midazolam

11.2.2. Alprazolam

11.2.3. Diazepam

11.2.4. Lorazepam

11.2.5. Phenytoin

11.2.6. Fosphenytoin

11.2.7. Others

11.3. Market Value Forecast, by Type, 2018–2030

11.3.1. Repetitive Seizures

11.3.2. Status Epilepticus

11.3.2.1. Convulsive Status Epilepticus

11.3.2.2. Non-convulsive Status Epilepticus

11.3.3. Others

11.4. Market Value Forecast, by Route of Administration, 2018–2030

11.4.1. Oral/Buccal

11.4.2. Rectal

11.4.3. Nasal

11.4.4. Parenteral

11.5. Market Value Forecast, by Distribution Channel, 2018–2030

11.5.1. Hospital Pharmacies

11.5.2. Retail Pharmacies

11.5.3. Online Pharmacies

11.6. Market Value Forecast, by Country, 2018–2030

11.6.1. U.S.

11.6.2. Canada

11.7. Market Attractiveness Analysis

11.7.1. By Therapeutics

11.7.2. By Type

11.7.3. By Route of Administration

11.7.4. By Distribution Channel

11.7.5. By Country

12. Europe Epileptic Seizures Treatment Market Analysis and Forecast

12.1. Introduction

12.1.1. Key Findings

12.2. Market Value Forecast, by Therapeutics, 2018–2030

12.2.1. Midazolam

12.2.2. Alprazolam

12.2.3. Diazepam

12.2.4. Lorazepam

12.2.5. Phenytoin

12.2.6. Fosphenytoin

12.2.7. Others

12.3. Market Value Forecast, by Type, 2018–2030

12.3.1. Repetitive Seizures

12.3.2. Status Epilepticus

12.3.2.1. Convulsive Status Epilepticus

12.3.2.2. Non-convulsive Status Epilepticus

12.3.3. Others

12.4. Market Value Forecast, by Route of Administration, 2018–2030

12.4.1. Oral/Buccal

12.4.2. Rectal

12.4.3. Nasal

12.4.4. Parenteral

12.5. Market Value Forecast, by Distribution Channel, 2018–2030

12.5.1. Hospital Pharmacies

12.5.2. Retail Pharmacies

12.5.3. Online Pharmacies

12.6. Market Value Forecast, by Country/Sub-region, 2018–2030

12.6.1. Germany

12.6.2. U.K.

12.6.3. France

12.6.4. Spain

12.6.5. Italy

12.6.6. Rest of Europe

12.7. Market Attractiveness Analysis

12.7.1. By Therapeutics

12.7.2. By Type

12.7.3. By Route of Administration

12.7.4. By Distribution Channel

12.7.5. By Country/Sub-region

13. Asia Pacific Epileptic Seizures Treatment Market Analysis and Forecast

13.1. Introduction

13.1.1. Key Findings

13.2. Market Value Forecast, by Therapeutics, 2018–2030

13.2.1. Midazolam

13.2.2. Alprazolam

13.2.3. Diazepam

13.2.4. Lorazepam

13.2.5. Phenytoin

13.2.6. Fosphenytoin

13.2.7. Others

13.3. Market Value Forecast, by Type, 2018–2030

13.3.1. Repetitive Seizures

13.3.2. Status Epilepticus

13.3.2.1. Convulsive Status Epilepticus

13.3.2.2. Non-convulsive Status Epilepticus

13.3.3. Others

13.4. Market Value Forecast, by Route of Administration, 2018–2030

13.4.1. Oral/Buccal

13.4.2. Rectal

13.4.3. Nasal

13.4.4. Parenteral

13.5. Market Value Forecast, by Distribution Channel, 2018–2030

13.5.1. Hospital Pharmacies

13.5.2. Retail Pharmacies

13.5.3. Online Pharmacies

13.6. Market Value Forecast, by Country/Sub-region, 2018–2030

13.6.1. China

13.6.2. Japan

13.6.3. India

13.6.4. Australia & New Zealand

13.6.5. Rest of Asia Pacific

13.7. Market Attractiveness Analysis

13.7.1. By Therapeutics

13.7.2. By Type

13.7.3. By Route of Administration

13.7.4. By Distribution Channel

13.7.5. By Country/Sub-region

14. Latin America Epileptic Seizures Treatment Market Analysis and Forecast

14.1. Introduction

14.1.1. Key Findings

14.2. Market Value Forecast, by Therapeutics, 2018–2030

14.2.1. Midazolam

14.2.2. Alprazolam

14.2.3. Diazepam

14.2.4. Lorazepam

14.2.5. Phenytoin

14.2.6. Fosphenytoin

14.2.7. Others

14.3. Market Value Forecast, by Type, 2018–2030

14.3.1. Repetitive Seizures

14.3.2. Status Epilepticus

14.3.2.1. Convulsive Status Epilepticus

14.3.2.2. Non-convulsive Status Epilepticus

14.3.3. Others

14.4. Market Value Forecast, by Route of Administration, 2018–2030

14.4.1. Oral/Buccal

14.4.2. Rectal

14.4.3. Nasal

14.4.4. Parenteral

14.5. Market Value Forecast, by Distribution Channel, 2018–2030

14.5.1. Hospital Pharmacies

14.5.2. Retail Pharmacies

14.5.3. Online Pharmacies

14.6. Market Value Forecast, by Country/Sub-region, 2018–2030

14.6.1. Brazil

14.6.2. Mexico

14.6.3. Rest of Latin America

14.7. Market Attractiveness Analysis

14.7.1. By Therapeutics

14.7.2. By Type

14.7.3. By Route of Administration

14.7.4. By Distribution Channel

14.7.5. By Country/Sub-region

15. Middle East & Africa Epileptic Seizures Treatment Market Analysis and Forecast

15.1. Introduction

15.1.1. Key Findings

15.2. Market Value Forecast, by Therapeutics, 2018–2030

15.2.1. Midazolam

15.2.2. Alprazolam

15.2.3. Diazepam

15.2.4. Lorazepam

15.2.5. Phenytoin

15.2.6. Fosphenytoin

15.2.7. Others

15.3. Market Value Forecast, by Type, 2018–2030

15.3.1. Repetitive Seizures

15.3.2. Status Epilepticus

15.3.2.1. Convulsive Status Epilepticus

15.3.2.2. Non-convulsive Status Epilepticus

15.3.3. Others

15.4. Market Value Forecast, by Route of Administration, 2018–2030

15.4.1. Oral/Buccal

15.4.2. Rectal

15.4.3. Nasal

15.4.4. Parenteral

15.5. Market Value Forecast, by Distribution Channel, 2018–2030

15.5.1. Hospital Pharmacies

15.5.2. Retail Pharmacies

15.5.3. Online Pharmacies

15.6. Market Value Forecast, by Country/Sub-region, 2018–2030

15.6.1. GCC Countries

15.6.2. South Africa

15.6.3. Rest of Middle East & Africa

15.7. Market Attractiveness Analysis

15.7.1. By Therapeutics

15.7.2. By Type

15.7.3. By Route of Administration

15.7.4. By Distribution Channel

15.7.5. By Country/Sub-region

16. Competition Landscape

16.1. Market Player – Competition Matrix (by tier and size of companies)

16.2. Market Share/Position Analysis, by Company, 2019

16.3. Competitive Business Strategies

16.4. Company Profiles

16.4.1.Bausch Health Companies, Inc.

16.4.1.1. Company Overview (HQ, Business Segments, Employee Strength)

16.4.1.2. Company Financials

16.4.1.3. Growth Strategies

16.4.1.4. SWOT Analysis

16.4.2.GlaxoSmithKline plc.

16.4.2.1. Company Overview (HQ, Business Segments, Employee Strength)

16.4.2.2. Company Financials

16.4.2.3. Growth Strategies

16.4.2.4. SWOT Analysis

16.4.3.UCB S.A.

16.4.3.1. Company Overview (HQ, Business Segments, Employee Strength)

16.4.3.2. Company Financials

16.4.3.3. Growth Strategies

16.4.3.4. SWOT Analysis

16.4.4. Pfizer, Inc.

16.4.4.1. Company Overview (HQ, Business Segments, Employee Strength)

16.4.4.2. Company Financials

16.4.4.3. Growth Strategies

16.4.4.4. SWOT Analysis

16.4.5.Apotex, Inc.

16.4.5.1. Company Overview (HQ, Business Segments, Employee Strength)

16.4.5.2. Company Financials

16.4.5.3. Growth Strategies

16.4.5.4. SWOT Analysis

16.4.6.Alexza Pharmaceuticals, Inc.

16.4.6.1. Company Overview (HQ, Business Segments, Employee Strength)

16.4.6.2. Company Financials

16.4.6.3. Growth Strategies

16.4.6.4. SWOT Analysis

16.4.7. Neurelis, Inc.

16.4.7.1. Company Overview (HQ, Business Segments, Employee Strength)

16.4.7.2. Company Financials

16.4.7.3. Growth Strategies

16.4.7.4. SWOT Analysis

16.4.8.Veriton Pharma

16.4.8.1. Company Overview (HQ, Business Segments, Employee Strength)

16.4.8.2. Company Financials

16.4.8.3. Growth Strategies

16.4.8.4. SWOT Analysis

List of Tables

Table 01: Pipeline Analysis

Table 02: Global Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Therapeutics, 2018–2030

Table 03: Global Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Type, 2018–2030

Table 04: Global Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Status Epilepticus, 2018–2030

Table 05: Global Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2018–2030

Table 06: Global Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030

Table 07: Global Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Region, 2018–2030

Table 08: North America Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Country, 2018–2030

Table 09: North America Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Therapeutics, 2018–2030

Table 10: North America Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Type, 2018–2030

Table 11: North America Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Status Epilepticus, 2018–2030

Table 12: North America Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2018–2030

Table 13: North America Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030

Table 14: Europe Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 15: Europe Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Therapeutics, 2018–2030

Table 16: Europe Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Type, 2018–2030

Table 17: Europe Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Status Epilepticus, 2018–2030

Table 18: Europe Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2018–2030

Table 19: Europe Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030

Table 20: Asia Pacific Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 21: Asia Pacific Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Therapeutics, 2018–2030

Table 22: Asia Pacific Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Type, 2018–2030

Table 23: Asia Pacific Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Status Epilepticus, 2018–2030

Table 24: Asia Pacific Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2018–2030

Table 25: Asia Pacific Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030

Table 26: Latin America Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 27: Latin America Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Therapeutics, 2018–2030

Table 28: Latin America Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Type, 2018–2030

Table 29: Latin America Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Status Epilepticus, 2018–2030

Table 30: Latin America Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2018–2030

Table 31: Latin America Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030

Table 32: Middle East & Africa Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 33: Middle East & Africa Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Therapeutics, 2018–2030

Table 34: Middle East & Africa Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Type, 2018–2030

Table 35: Middle East & Africa Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Status Epilepticus, 2018–2030

Table 36: Middle East & Africa Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Route of Administration, 2018–2030

Table 37: Middle East & Africa Epileptic Seizures Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030